S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Cutera Stock Forecast, Price & News

+0.04 (+0.11%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
531,048 shs
Average Volume
385,388 shs
Market Capitalization
$681.84 million
P/E Ratio
Dividend Yield
Price Target

Cutera Stock Forecast (MarketRank)

Analyst Rating
3.00 Rating Score
88.1% Upside
$70.60 Price Target
Short Interest
21.66% of Float Sold Short
Dividend Strength
News Sentiment
Insider Trading
Acquiring Shares
$49.92 K Bought Last Quarter
Proj. Earnings Growth
From ($1.14) to $0.26 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.76 out of 5 stars

Computer And Technology Sector

454th out of 936 stocks

Electromedical Equipment Industry

12th out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive CUTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter.

Cutera logo

About Cutera (NASDAQ:CUTR)

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.

CUTR Stock News Headlines

Form 8-K CUTERA INC For: May 24 - StreetInsider.com
Cutera Q1 2022 Earnings Preview - Seeking Alpha
See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
$2.06 million
Pretax Margin


Sales & Book Value

Annual Sales
$231.27 million
Cash Flow
$0.30 per share
Book Value
$3.15 per share


Free Float
Market Cap
$681.84 million

Social Links

Cutera Frequently Asked Questions

Should I buy or sell Cutera stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cutera stock.
View analyst ratings for Cutera
or view top-rated stocks.

What is Cutera's stock price forecast for 2022?

3 Wall Street research analysts have issued twelve-month price targets for Cutera's stock. Their CUTR stock forecasts range from $60.00 to $80.00. On average, they predict Cutera's stock price to reach $70.60 in the next twelve months. This suggests a possible upside of 88.1% from the stock's current price.
View analysts' price targets for Cutera
or view top-rated stocks among Wall Street analysts.

How has Cutera's stock performed in 2022?

Cutera's stock was trading at $41.32 at the beginning of the year. Since then, CUTR stock has decreased by 9.1% and is now trading at $37.54.
View the best growth stocks for 2022 here

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Cutera

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings data on Tuesday, May, 10th. The medical device company reported ($0.84) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.75. The medical device company had revenue of $58.01 million for the quarter, compared to the consensus estimate of $57.26 million. Cutera had a negative trailing twelve-month return on equity of 24.42% and a negative net margin of 5.31%. The firm's revenue for the quarter was up 16.8% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.02) EPS.
View Cutera's earnings history

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $255.00 million-$260.00 million, compared to the consensus revenue estimate of $260.66 million.

Who are Cutera's key executives?

Cutera's management team includes the following people:

What is David H. Mowry's approval rating as Cutera's CEO?

1 employees have rated Cutera CEO David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among Cutera's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Square (SQ) and Twilio (TWLO).

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $37.54.

How much money does Cutera make?

Cutera (NASDAQ:CUTR) has a market capitalization of $681.84 million and generates $231.27 million in revenue each year. The medical device company earns $2.06 million in net income (profit) each year or ($0.75) on an earnings per share basis.

How many employees does Cutera have?

Cutera employs 461 workers across the globe.

When was Cutera founded?

Cutera was founded in 1998.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for Cutera is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444.

This page (NASDAQ:CUTR) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.